MedTrace Logo

Self-administration of Patients Own Drugs During Hospital Stay

NCT03541421 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2020-03-25

No results posted yet for this study

Summary

Background Medication administration errors occur in around 20% of administrations. Patient involvement (PI) is recommended and self-management support e.g. as self-administration of patient's own drugs during hospital stay is a central component of practising PI.

Aim To investigate whether PI in administering drugs in hospital affects the number of medication errors, medication adherence and patient satisfaction and whether it is economically advantageously.

Materials and methods The PhD Study is performed at the Department of Cardiology, Randers Regional Hospital.

The study design is "complex intervention" and the PhD study therefore consists of three studies. In study 1 the intervention is developed, investigated for feasibility and pilot-tested in small scale. In study 2 and 3 the intervention is evaluated within a RCT with outcomes as medication errors, medication adherence, patient satisfaction and cost-effectiveness.

Conditions

  • Patient Involvement
  • Medication Errors
  • Self Administration
  • Medication Adherence
  • Patient Satisfaction
  • Health Economics

Interventions

OTHER

Patient involvement in administration of drugs

The patient´s own drugs and an updated medication list will be placed in a lockable bedside table. During hospitalization the patient is responsible for taking his own medication. If a new drug is prescribed, the patient will be involved and instructed about it. Furthermore the smallest package will be delivered so that the patient can begin self-administration of the new drug during hospitalization.

Sponsors & Collaborators

  • Randers Regional Hospital

    collaborator OTHER

  • Hospital Pharmacy Central Denmark Region

    collaborator UNKNOWN

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Charlotte A. Sørensen, Ph.d.student · Health, Aarhus University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-06
Primary Completion
2018-09-26
Completion
2019-05-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03541421 on ClinicalTrials.gov